JMKX000197
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JMKX000197, covering 2025-04-04 to 2025-04-04. Get the full timeline:
Most recent: Clinical Trial Update: A Phase Ib Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion [Phase 1]